Vistagen Therapeutics Inc (NQ: VTGN )
3.920
+0.260
(+7.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Vistagen Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Recap: Vistagen Therapeutics Q3 Earnings
February 13, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
VistaGen Therapeutics's Earnings: A Preview
February 12, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
VistaGen Therapeutics Earnings Preview
November 08, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20240213784404/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg)
Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
February 13, 2024
From Vistagen
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-fingers.jpg)
![](https://mms.businesswire.com/media/20240206380065/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/03/penny-stocks-1024x576.png)
![](https://mms.businesswire.com/media/20231227642635/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/04/vtgn.png?width=1200&height=800&fit=crop)
Undervalued VistaGen Therapeutics, Analyst Highlights Potential In Anxiety Treatment
December 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/14/vtgn.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231109410625/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg)
Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results
November 09, 2023
From Vistagen
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231108051546/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg)
Vistagen to Present at Stifel 2023 Healthcare Conference
November 08, 2023
From Vistagen
Via Business Wire
![](https://mms.businesswire.com/media/20231107516146/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20231106711502/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/17/image22.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
October 05, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20231005492188/en/1564398/5/Vistagen_Primary-Logo_Blue.jpg)
Vistagen to Present at Jefferies Inaugural Biotech CNS/Neuro Summit
October 05, 2023
From Vistagen
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.